Study finds link between eye diseases and Alzheimer's

Image
ANI Washington D.C. [USA]
Last Updated : Aug 08 2018 | 12:25 PM IST

There is no simple way to detect Alzheimer's. But now, in a new study, researchers have found that eye conditions provide new lens screening for the disease.

A study of 3,877 randomly selected patients found a significant link between three degenerative eye diseases - age-related macular degeneration, diabetic retinopathy and glaucoma - and Alzheimer' disease.

The results offer physicians a new way to detect those at a higher risk of this disorder, which causes memory loss and other symptoms of cognitive decline.

"We don't mean people with these eye conditions will get Alzheimer's disease. The main message from this study is that ophthalmologists should be more aware of the risks of developing dementia for people with these eye conditions and primary care doctors seeing patients with these eye conditions might be more careful on checking on possible dementia or memory loss," said lead researcher Dr. Cecilia Lee at the UW School of Medicine

The participants in the study were aged 65 and older and did not have Alzheimer's disease at the time of enrollment. Over the five-year study, 792 cases of Alzheimer's disease were diagnosed by a committee of dementia experts. Patients with age-related macular degeneration, diabetic retinopathy, or glaucoma were at 40 percent to 50 percent greater risk of developing Alzheimer's disease compared to similar people without these eye conditions. Cataract diagnosis was not an Alzheimer's disease risk factor.

"What we found was not subtle," said Dr. Paul Crane, at the UW School of Medicine. "This study solidifies that there are mechanistic things we can learn from the brain by looking at the eye."

Lee said anything happening in the eye may relate to what's happening in the brain, an extension of the central nervous system. The possible connections need more study. She said a better understanding of neurodegeneration in the eye and the brain could bring more success in diagnosing Alzheimer's early and developing better treatments.

The study has been published in the journal Alzheimer's & Dementia.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 08 2018 | 12:06 PM IST

Next Story